Rimantadine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Rimantadine. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Insomia | 7% |
| Depression | 3.5% |
| Nausea | 2.8% |
| Insomnia | 2.1% |
| Impaired concentration | 2.1% |
| Dizziness | 1.9% |
| Vomiting | 1.7% |
| Anorexia | 1.6% |
| Dry mouth | 1.5% |
| Headache | 1.4% |
| Abdominal pain | 1.4% |
| Asthenia | 1.4% |
| Nervousness | 1.3% |
| Fatigue | 1% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Rimantadine hydrochloride tablet is indicated for the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults (17 years and older). Rimantadine hydrochloride tablet is indicated for prophylaxis against influenza A virus in children (1 year to 16 years of age).
Medical disclaimer: Always consult a qualified healthcare professional about any medication.
Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.
Compare lab testing options near you ↗ (affiliate link)